Journal article · 2018 · Open access
HEALTH-RELATED QUALITY OF LIFE IN EARLY BREAST CANCER PATIENTS WITH HORMONE RESPONSIVE
International Journal of Pharmacy and Pharmaceutical Sciences, 10(12), 47 · Published 1 December 2018 · DOI 10.22159/ijpps.2018v10i12.29648
In brief
“HEALTH-RELATED QUALITY OF LIFE IN EARLY BREAST CANCER PATIENTS WITH HORMONE RESPONSIVE” is a 2018 journal article by Fef Rukminingsih and 3 co-authors, published in International Journal of Pharmacy and Pharmaceutical Sciences. OpenAlex counts 6 citations as of 22 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at International Journal of Pharmacy and Pharmaceutical Sciences.
- Citations
- 6
- Most cited in
- 2019 (3)
- Field-weighted impact
- 0.39
- References
- 16
- Authors
- 4
Abstract
Objective: The management of early breast cancer (EBC) is performed with a series of treatments consisting of surgery and systemic therapy, along with long-term endocrine therapy for hormone responsive. The treatment generates a high illness effect that will affect the life quality of EBC patients. The objective of this study was to measure EBC patients’ quality of life after undergoing the treatment.Methods: A cross-sectional study was conducted by interviewing EBC patients using EQ-5D-5L instrument at private hospitals in Yogyakarta and Semarang, Indonesia. The EBC patients were women aged 18-60 y who had undergone surgery in 2010-2013 and received endocrine therapy.Results: Of the 71 patients identified, 45 patients were in disease-free survival (DFS) state, 8 patients were in locoregional recurrence (LR), and 18 patients were in metastasis (M) state. Mobility and self-care problems occurred in patients who had metastasis (4.23%). The problem of usual activities occured in patients who had recurrence (22.54%). Most of the patients (84.51%) had pain problem, and all patients had an anxiety problem. The mean utility score (SD) in DFS patients was 0.841 (0.052), in LR patients was 0.758 (0.092), and in patients who had metastasis was 0.653 (0.104). The mean scores of EQ-5D VAS (SD) for EBC patients in DFS, LR and M health state were 86.56 (6.29), 81.88 (5.30), and 69.17 (5.75), respectively.Conclusion: The health states of EBC significantly affect HRQOL of patients. Efforts should be made to improve the quality of life of EBC patients especially in terms of pain and anxiety reduction.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Rukminingsih, F., Andayani, T. M., Rahmawati, F., & Widayati, K. (2018). HEALTH-RELATED QUALITY OF LIFE IN EARLY BREAST CANCER PATIENTS WITH HORMONE RESPONSIVE. International Journal of Pharmacy and Pharmaceutical Sciences, 10(12), 47. https://doi.org/10.22159/ijpps.2018v10i12.29648
MLA 9
Rukminingsih, Fef, et al. “HEALTH-RELATED QUALITY OF LIFE IN EARLY BREAST CANCER PATIENTS WITH HORMONE RESPONSIVE.” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 10, no. 12, 2018, p. 47. https://doi.org/10.22159/ijpps.2018v10i12.29648.
Chicago
Rukminingsih, Fef, Tri Murti Andayani, Fita Rahmawati, and Kartika Widayati. 2018. “HEALTH-RELATED QUALITY OF LIFE IN EARLY BREAST CANCER PATIENTS WITH HORMONE RESPONSIVE.” International Journal of Pharmacy and Pharmaceutical Sciences 10 (12): 47. https://doi.org/10.22159/ijpps.2018v10i12.29648.
Harvard
Rukminingsih, F. et al. (2018) ‘HEALTH-RELATED QUALITY OF LIFE IN EARLY BREAST CANCER PATIENTS WITH HORMONE RESPONSIVE’, International Journal of Pharmacy and Pharmaceutical Sciences, 10(12), p. 47. doi:10.22159/ijpps.2018v10i12.29648.
IEEE
F. Rukminingsih, T. M. Andayani, F. Rahmawati, and K. Widayati, “HEALTH-RELATED QUALITY OF LIFE IN EARLY BREAST CANCER PATIENTS WITH HORMONE RESPONSIVE,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 10, no. 12, p. 47, 2018, doi: 10.22159/ijpps.2018v10i12.29648.
BibTeX
@article{rukminingsih2018health,
title = {{HEALTH-RELATED QUALITY OF LIFE IN EARLY BREAST CANCER PATIENTS WITH HORMONE RESPONSIVE}},
author = {Rukminingsih, Fef and Andayani, Tri Murti and Rahmawati, Fita and Widayati, Kartika},
journal = {International Journal of Pharmacy and Pharmaceutical Sciences},
year = {2018},
volume = {10},
number = {12},
pages = {47},
doi = {10.22159/ijpps.2018v10i12.29648},
url = {https://doi.org/10.22159/ijpps.2018v10i12.29648}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2019 | 3 | |
| 2020 | 1 | |
| 2023 | 1 | |
| 2024 | 1 |
Its field-weighted citation impact is 0.39: it has been cited 0.39 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › Cancer survivorship and care
- health-related quality of life
- early breast cancer
- hormone receptor-positive breast cancer
- endocrine therapy
- breast cancer surgery
- EQ-5D-5L
- disease-free survival
- locoregional recurrence
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Rukminingsih, F., Andayani, T. M., Rahmawati, F., & Widayati, K. (2018). HEALTH-RELATED QUALITY OF LIFE IN EARLY BREAST CANCER PATIENTS WITH HORMONE RESPONSIVE. International Journal of Pharmacy and Pharmaceutical Sciences, 10(12), 47. https://doi.org/10.22159/ijpps.2018v10i12.29648
How many times has this paper been cited?
6 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at International Journal of Pharmacy and Pharmaceutical Sciences: sign in and open the PDF from this page.
Who wrote this paper?
Fef Rukminingsih, Tri Murti Andayani, Fita Rahmawati, Kartika Widayati.
What is the DOI of this paper?
10.22159/ijpps.2018v10i12.29648, permanently at https://doi.org/10.22159/ijpps.2018v10i12.29648. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.